Abdul AB, Al-Zubairi AS, Abdelwahab SI (2011) Eleucine indica possesses antioxidant, antibacterial and cytotoxic properties. Evidence-based Complement Altern Med DOI. https://doi.org/10.1093/ecam/nep091

Article  Google Scholar 

Ali TB, Schleret TR, Reilly BM (2015) Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United States and Canada. PLoS ONE 10(12):1–10

Article  Google Scholar 

Bachurin SO, Bovina EV, Ustyugov AA (2017) Drugs in clinical trials for Alzheimer’s Disease: the Major trends. Med Res Rev 5:1186–1225

Article  Google Scholar 

Bhuvanendran S, Kumari Y, Othman I (2018) Amelioration of cognitive deficit by Embelin in a Scopolamine-Induced Alzheimer’s Disease-Like Condition in a rat model. Front Pharmacol 9(6):1–12

Google Scholar 

Blennow K, Leon MJ, De, Zetterberg H (2006) Alzheimer’s Disease 368:387–403

Bourin M, Hascoet M (2003) The mouse light/dark box test. Eur J Pharmacol 463:55–65

Article  CAS  PubMed  Google Scholar 

Clos M, Bunzeck N (2019) Dopamine is a double-edged sword: dopaminergic modulation enhances memory retrieval performance but impairs metacognition. Neuropsychopharmacology 44(3):555–563

Article  CAS  PubMed  Google Scholar 

Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77

Article  CAS  PubMed  Google Scholar 

Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmaco 7(2):88–95

Article  CAS  Google Scholar 

Gauthier S (2001) Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer’s disease: epidemiology and management. Drugs Aging 18(11):853–862

Article  CAS  PubMed  Google Scholar 

Gella A, Durany N (2009) Oxidative stress in Alzheimer disease. Cell Adh Migr 3(1):88–93

Article  PubMed  PubMed Central  Google Scholar 

Huang L-K, Kuan Y-C, Lin H-W (2023) Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update3. J Biomed Sci 30(1):834

Article  Google Scholar 

Ishola IO, Ikuomola BO, Adeyemi OO (2018) Protective role of Spondias mombin leaf and Cola acuminata seed extracts against scopolamine-induced cognitive dysfunction. Alexandria J Med 54(1):27–39

Article  Google Scholar 

Jewart RD, Green J, Lu CJ (2005) Cognitive, behavioral and physiological changes in Alzheimer disease patients as a function of incontinence medications. Am J Geriatr Psychiatry 13:324–328

Article  PubMed  Google Scholar 

Katzman R, Kawas C (1998) Risk factors for Alzheimer’s disease. Neuro Sci News 1:27–44

CAS  Google Scholar 

Khale AS, Kolhe SU, Tembhurne SV (2018) Neuropharmacological evaluation of Sesbania sesban using experimental animals. World J Pharm Res 7(12):698–671

Google Scholar 

Laura R, Luisa M (2004) Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats. Exp Neurol 189(1):162–172

Article  Google Scholar 

Lowry H, Randall RJ (1951) Protein Measurement with the Folin Phenol Reagent. J Biol Chem 193(1):265–275

Article  CAS  PubMed  Google Scholar 

Mohammad HG, Arezoo R (2023) Minocycline alleviated scopolamine-induced amnesia by regulating antioxidant and cholinergic function. Heliyon 9(2):e13452

Article  Google Scholar 

Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by. Thiobarbituric acid Reaction 95(2):351–358

CAS  Google Scholar 

Okokon JE, Imabong E, Obot J (2010) Antiplasmodial and antidiabetic activities of Eleusine indica. Int J Drug Dev Res 2(3):493–500

Google Scholar 

Ong SL, Nalamolu KR, Lai HY (2017) Potential lipid-lowering effects of Eleusine indica(L) Gaertn. Extract on high-fat-diet-induced hyperlipidemic rats. Pharmacogn Mag 13(49):S1–9

Article  PubMed  PubMed Central  Google Scholar 

Ornish D, Madison C, Kivipelto M (2024) Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial1. Alzheimer’s Res Ther 16(1):1222

Google Scholar 

Palle S, Neerati P (2017) Quercetin nanoparticles attenuate scopolamine-induced spatial memory deficits and pathological damages in rats. Bull Fac Pharm Cairo Univ 55(1):101–106

Google Scholar 

Ramakrishnan P, Chandrasekhar T, Muralidharan P (2015) Cognitive enhancing, anti-acetylcholinesterase, and antioxidant properties of Tagetes patula on scopolamine-induced amnesia in mice. Int J Green Pharm 9(3):167–174

Article  CAS  Google Scholar 

Shalavadi MH, Chandrashekhar VM, Avinash SP, Sowmya C, Ramkishan A (2012) Neuroprotective activity of stereospermum suaveolens DC against 6-OHDA induced parkinson’s disease model. Indian J Pharmacol 44(6):737–743

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sukor S, Zahari Z, Rahim N (2022) Chemical constituents and antiproliferative activity of Eleusine indica(L.) Gaertn. Sains Malaysiana 51(3):873–882

Article  Google Scholar 

Teixeira P, Coelho L, Conceição I (2013) Oxidative Stress Responses Histological Hepatic Alterations in 29(1):29–38

Therese M, Garcia H, Malaguit JA (2018) Antiurolithiatic activity of ethanolic extract of Eleusine indica Linn. (Poaceae) leaves in ethylene glycol-induced urolithiasis in male Sprague Dawley rats. Asia Pac J Allied Heal Sci 1:90–112

Google Scholar 

Trease G, Evans SM, Pharmacognosy (2002) 15th edn, (London: Bailer Tindal), 23–67

Ulep MG, Saraon SK, Mclea S (2017a) Alzheimer disease. TJNP J Nurse Pract 14(3):129–135

Ulep MG, Saraon SK, Mclea S (2017b) Alzheimer disease. TJNP J Nurse Pract 1(3):129–135